Market Tracker

07/29 5:16pm ET

Becton Dickinson and Co (NYSE:BDX)

176.00
Delayed Data
As of Jul 29
 +0.04 / +0.02%
Today’s Change
128.87
Today|||52-Week Range
177.50
+14.22%
Year-to-Date
Becton, Dickinson (BDX) Q3 Earnings: What's in the Cards?
Jul 29 / Zacks.com - Paid Partner Content
3 Healthcare Stocks to Hold Forever
Jul 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close175.96
Today’s open175.65
Day’s range175.37 - 176.98
Volume775,782
Average volume (3 months)888,395
Market cap$37.3B
Dividend yield1.50%
Data as of 4:01pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.60%
Earnings growth (next 5 years)+11.25%
Revenue growth (last year)+21.94%
P/E ratio47.1
Price/Sales2.68
Price/Book5.18

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...-0.06-0.25%
SYKStryker Corp+1.32+1.15%
ZBHZimmer Biomet Holdin...+3.67+2.88%
EWEdwards Lifesciences...+1.53+1.35%
Data as of 4:05pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$2.21
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts